Kist-van Holthe Joana E, Ho Ping L, Stablein Donald, Harmon William E, Baum Michelle A
Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Pediatr Transplant. 2005 Jun;9(3):305-10. doi: 10.1111/j.1399-3046.2005.00311.x.
In some children with bilateral Wilms' tumor, reduction of tumor burden cannot be accomplished without total nephrectomy. In Denys-Drash syndrome, nephrectomy is required for associated Wilms' tumor or after progression to end stage renal disease secondary to diffuse mesangial sclerosis because of risk of development of Wilms' tumor. Current recommendation is to wait at least 1-2 yr after completion of chemotherapy for Wilms' tumor before renal transplantation. The North American Pediatric Renal Transplant Cooperative Study dialysis (1992-2001) and transplant registries (1987-2002) were analyzed, comparing children 0-18 yr old with Wilms' tumor and Denys-Drash syndrome to other primary diagnoses. There were 37 children with Wilms' tumor and 33 with Denys-Drash syndrome in the dialysis registry. Of these, 10 children with Wilms' tumor and three with Denys-Drash syndrome did not receive a renal transplant and all died. The cause of death was Wilms' tumor in eight children with Wilms' tumor and in one with Denys-Drash syndrome. The transplant registry included 43 children with Wilms' tumor, 43 children with Denys-Drash syndrome, and 7469 patients with other diagnoses. Acute rejection, graft and patient survival profiles from all three groups at 6 months, 1 and 3 yr post-transplant were comparable. There were no graft failures or deaths because of recurrent Wilms' tumor in the Drash group. There was one death with Wilms' tumor in the Wilms' group - a 2.5-yr-old child transplanted after 6 months of dialysis who died of Wilms' <6 months after renal transplantation. In conclusion, most children dialyzed because of Wilms' tumor and Denys-Drash syndrome who did not receive a renal transplant died of Wilms' tumor. However, the outcomes of children with Wilms' tumor and Denys-Drash syndrome who proceeded to renal transplantation are comparable with children with other diagnoses, with no graft failures because of recurrence and only one death from Wilms' tumor in a Wilms' patient who received only a short course of dialysis prior to transplantation. Current practices in children with Wilms' tumor and Denys-Drash syndrome appear to be on target to portend good outcome following renal transplantation.
在一些双侧肾母细胞瘤患儿中,不进行全肾切除术就无法减轻肿瘤负荷。在迪尼-德拉斯综合征中,由于存在肾母细胞瘤发生风险,对于相关的肾母细胞瘤或在进展为弥漫性系膜硬化继发的终末期肾病后,需要进行肾切除术。目前的建议是,在完成肾母细胞瘤化疗后至少等待1 - 2年再进行肾移植。对北美儿科肾移植协作研究透析登记处(1992 - 2001年)和移植登记处(1987 - 2002年)进行了分析,将0 - 18岁患有肾母细胞瘤和迪尼-德拉斯综合征的儿童与其他原发性诊断的儿童进行比较。透析登记处有37名肾母细胞瘤患儿和33名迪尼-德拉斯综合征患儿。其中,10名肾母细胞瘤患儿和3名迪尼-德拉斯综合征患儿未接受肾移植,全部死亡。8名肾母细胞瘤患儿和1名迪尼-德拉斯综合征患儿的死因是肾母细胞瘤。移植登记处包括43名肾母细胞瘤患儿、43名迪尼-德拉斯综合征患儿和7469名其他诊断的患者。移植后6个月、1年和3年时,三组的急性排斥反应、移植物和患者生存情况相当。迪尼-德拉斯组没有因肾母细胞瘤复发导致的移植物失败或死亡。肾母细胞瘤组有1例因肾母细胞瘤死亡——一名2.5岁儿童在透析6个月后接受移植,肾移植后<6个月死于肾母细胞瘤。总之,大多数因肾母细胞瘤和迪尼-德拉斯综合征接受透析但未接受肾移植的儿童死于肾母细胞瘤。然而,肾母细胞瘤和迪尼-德拉斯综合征患儿进行肾移植的结果与其他诊断的患儿相当,没有因复发导致的移植物失败,且在移植前仅接受短程透析的肾母细胞瘤患者中只有1例死于肾母细胞瘤。目前针对肾母细胞瘤和迪尼-德拉斯综合征患儿的治疗方法似乎预示着肾移植后会有良好的结果。